kabutan

NIPPON CHEMIPHAR CO., LTD.(4539) Summary

4539
TSE Standard
NIPPON CHEMIPHAR CO., LTD.
1,680
JPY
-21
(-1.23%)
Jan 29, 3:30 pm JST
10.98
USD
Jan 29, 1:30 am EST
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
40.4
PBR
0.32
Yield
2.98%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,680 JPY 10.97 USD
Previous Close Jan 28
1,701 JPY 11.14 USD
High Jan 29, 1:34 pm
1,704 JPY 11.13 USD
Low Jan 29, 9:04 am
1,674 JPY 10.93 USD
Volume
4,800
Trading Value
8.00M JPY 0.05M USD
VWAP
1685.67 JPY 11.02 USD
Minimum Trading Value
168,000 JPY 1,098 USD
Market Cap
7.16B JPY 0.05B USD
Number of Trades
16
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly Low
1-Year Average
13
1-Year High Sep 11, 2025
83
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 176,000
Jan 16, 2026 0 177,200
Jan 9, 2026 0 177,100
Dec 26, 2025 0 184,900
Dec 19, 2025 0 187,500
Company Profile
NIPPON CHEMIPHAR CO., LTD. is a mid-sized pharmaceutical company. Its main focus is on generic drugs, with uric acid and pain relief medications as its core products. The company is also actively engaged in new drug development.
Sector
Pharmaceuticals
NIPPON CHEMIPHAR CO., LTD. operates in the medical, health, and beauty-related sectors, with pharmaceutical products at its core. In its primary pharmaceutical business, the company manufactures and sells prescription drugs, with a high proportion of generic medicines, while also pursuing new drug development. The company promotes its business in collaboration with domestic and overseas subsidiaries and affiliates. Additionally, it is involved in other ventures such as safety testing services, healthcare business, and real estate leasing. The group comprises six companies, establishing an integrated system from drug development to manufacturing and sales. While maintaining its strength in the prescription drug field, NIPPON CHEMIPHAR CO., LTD. has expanded into related areas, solidifying its position as a comprehensive medical and health-related enterprise.